The needle biopsy specimen was submitted for next-generation sequencing, which revealed a MEN1 gene mutation, and after further examination, a diagnosis of multiple endocrine neoplasia type 1 was made. This evidence concerns the gene MEN1 and multiple endocrine neoplasia type 1.